Most of the kinases predicted to be strongly activated included several members of the mitogen-activated protein kinase kinase kinase (MAP3K) family, including MAP3K1, MAP3K2, and MAP3K7, in patients with SLE_S and SLE_A compared with HC and those with RA. This evidence concerns the gene MAP3K2 and rheumatoid arthritis.